Predictive Factors for Differentiating Pancreatic Cancer-Associated Diabetes Mellitus from Common Type 2 Diabetes Mellitus for the Early Detection of Pancreatic Cancer.
Dong, Xin; Lou, Yan Bo; Mu, Yun Chuan; Kang, Mu Xing; Wu, Yu Lian.
; 98(4): 209-216, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30045045
Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.
Nabliudenie solidno-psevdopapilliarnoi opukholi podzheludochnoi zhelezy: osobennosti techeniia, slozhnosti v diagnostike.
Últimos avances sobre los tumores pancreáticos.
The implication of diabetes metabolomics in the early diagnosis and pathogenesis of pancreatic cancer.
[Advances in diagnosis and treatment of undifferentiated pancreatic carcinoma with osteoclast-like giant cells].
New-onset type 2 diabetes mellitus--A high-risk group suitable for the screening of pancreatic cancer?
CA 19-9: Biochemical and Clinical Aspects.
Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis.
Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer.
[Important issues need to be emphasized in the diagnosis and treatment of pancreatic cystic neoplasms].